Trial NCT00920556

View at ClinicalTrials.gov 
Org. Study IDs: 113222

Last trial update was posted on 2019-02-27

MeSH Interventions

Bortezomib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Study terminated.24 subjects enrolled;provided adequate data for decision making.

Limitations And Caveats

The study of Multiple Myeloma, was terminated early due to minimal efficacy signal observed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID